# The Effect of Sildenafil in Preterm Infants With Evolving Chronic Lung Disease

> **NCT00431418** · PHASE3 · COMPLETED · sponsor: **Mercy Hospital for Women, Australia** · enrollment: 20 (actual)

## Conditions studied

- Lung Diseases

## Interventions

- **DRUG:** Sildenafil
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00431418
- **Lead sponsor:** Mercy Hospital for Women, Australia
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-01
- **Primary completion:** 2010-07
- **Final completion:** 2012-06
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2015-09-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00431418

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00431418, "The Effect of Sildenafil in Preterm Infants With Evolving Chronic Lung Disease". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00431418. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*